Literature DB >> 15956349

Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa.

C Samuel Bradford1, Eliza A Walthers, Brian T Searcy, Frank L Moore.   

Abstract

A full-length cDNA that encodes a kappa (kappa) opioid receptor has been isolated from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa. The deduced protein contains 385 amino acids and possesses features commonly attributed to G protein-coupled receptors, such as seven putative transmembrane domains. The newt kappa receptor has 75% sequence identity to kappa opioid receptors cloned from mammals, and 66% sequence identity to the kappa opioid receptor reported for the zebrafish, with the greatest divergence in the extracellular N-terminus, the second and third extracellular loops and the intracellular C-terminus. Membranes isolated from COS-7 cells expressing the newt kappa receptor possessed a single, high-affinity (Kd = 1.5 nM) binding site for the kappa-selective agonist U69593. In competition binding assays, the expressed newt kappa receptor displayed high affinity for the kappa-selective agonists GR89696, dynorphin A(1-13), U69593, U50488 and BRL52537, as well as the kappa-selective antagonist nor-binaltorphimine and the non-selective antagonist naloxone. Rank order potencies and affinity constants were similar in competition binding studies that used either whole brain homogenates or membranes isolated from COS-7 cells expressing the newt kappa receptor. The expressed receptor displayed essentially no affinity for the delta-selective agonist DPDPE ([d-penicillamine, d-penicillamine]enkephalin), but showed moderate affinity for the mu-selective agonist DAMGO ([d-Ala-MePhe, Gly-ol]enkephalin) and moderately high affinity for nociceptin (orphanin FQ), the endogenous ligand for the opioid receptor-like (ORL)1 receptor. These findings support the conclusions that a gene for the kappa opioid receptor is expressed in amphibians and that the pharmacology of the newt kappa receptor closely matches mammalian kappa opioid receptors. However, the functional dichotomy between the classic opioid receptors (kappa, delta, mu) and ORL1 appears less strict in amphibians than in mammals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956349     DOI: 10.1677/jme.1.01711

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  6 in total

1.  Evolution of vertebrate opioid receptors.

Authors:  Susanne Dreborg; Görel Sundström; Tomas A Larsson; Dan Larhammar
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

2.  Single Amino Acid Variation Underlies Species-Specific Sensitivity to Amphibian Skin-Derived Opioid-like Peptides.

Authors:  Eyal Vardy; Maria F Sassano; Andrew J Rennekamp; Wesley K Kroeze; Philip D Mosier; Richard B Westkaemper; Craig W Stevens; Vsevolod Katritch; Raymond C Stevens; Randall T Peterson; Bryan L Roth
Journal:  Chem Biol       Date:  2015-06-18

3.  A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function.

Authors:  Chris M Brasel; Gregory W Sawyer; Craig W Stevens
Journal:  Eur J Pharmacol       Date:  2008-10-09       Impact factor: 4.432

4.  Estradiol interacts with an opioidergic network to achieve rapid modulation of a vocal pattern generator.

Authors:  Luke Remage-Healey; Andrew H Bass
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2009-12-25       Impact factor: 1.836

Review 5.  The evolution of vertebrate opioid receptors.

Authors:  Craig W Stevens
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

6.  Functional Stability of the Human Kappa Opioid Receptor Reconstituted in Nanodiscs Revealed by a Time-Resolved Scintillation Proximity Assay.

Authors:  Randi Westh Hansen; Xiaole Wang; Agnieszka Golab; Olivier Bornert; Christine Oswald; Renaud Wagner; Karen Laurence Martinez
Journal:  PLoS One       Date:  2016-04-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.